Edwards Lifesciences Corp (EW)vsOrthopediatrics Corp (KIDS)
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
KIDS
Orthopediatrics Corp
$16.92
+0.65%
HEALTHCARE · Cap: $472.22M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 2491% more annual revenue ($6.30B vs $243.30M). EW leads profitability with a 17.4% profit margin vs -16.3%. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
KIDS
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Margin of Safety
+72.6%
Fair Value
$62.94
Current Price
$16.92
$46.02 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -11.7% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : KIDS
The strongest argument for KIDS centers on Price/Book. Revenue growth of 13.3% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : KIDS
The primary concerns for KIDS are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a growth stock while KIDS is a turnaround play — different risk/reward profiles.
KIDS carries more volatility with a beta of 1.01 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
KIDS generates stronger free cash flow (-5M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 38/100), backed by strong 17.4% margins and 16.7% revenue growth. KIDS offers better value entry with a 72.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Orthopediatrics Corp
HEALTHCARE · MEDICAL DEVICES · USA
OrthoPediatrics Corp. The company is headquartered in Warsaw, Indiana.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?